//

 In recent years, a crop of companies have emerged that are using genomic sequencing to detect diseases in order to prevent the negative outcome of those diseases. It’s led to a budding ecosystem of startups that are crunching the data, as well as the cost of that sequencing coming down. But while we’re at the stage of getting the cost of genomic sequencing down and making it… Read More

from Startups – TechCrunch http://ift.tt/2fiX7aj